How a small biotech worked its way out of storage space during the industry’s biggest conference

"In its own way, Shasqi Inc. will draw a crowd around next week’s J.P. Morgan Healthcare Conference.

Yes, José Mejîa Oneto’s young San Francisco company has only eight employees and doesn’t possess a deep portfolio of drugs.

But Shasqi does offer a new way to boost the effectiveness and precision of drugs, launching its first cancer-fighting drug trial in humans in the second quarter. Perhaps just as importantly, it has four years of experience building a network of biotech industry business development executives at the industry’s biggest dealmaking conference."

Read the full article by Ron Leuthy here

‍